HONG KONG – November 03, 2026 -- D2 Intelligence, a subsidiary of Wenge AI (1956.HK), reported that its DocuMind platform processed a trade finance document of up to 10 pages in under 30 seconds in the HKMA GenA.I. Sandbox, against 10 to 20 minutes manually. The company presented the result alongside three other AI products at Hong Kong FinTech Week x StartmeupHK 2026, which drew more than 45,000 attendees from more than 120 economies.
DocuMind posts 95% extraction accuracy and 85% review automation in sandbox
DocuMind launched in September 2026 and targets financial services, insurance and public services. It runs on Wenge AI's DOMA architecture (Data, Ontology, Models and Agents) and combines document recognition, information extraction, cross-document verification and risk review in one workflow.
In the HKMA sandbox, extraction accuracy for core fields exceeded 95%, and the review automation rate was approximately 85%. Every conclusion retains its rationale, evidence and audit trail. The platform supports data masking, isolated environments and on-premises deployment.
Decitron reaches 81.20% Final Forecast Accuracy on PolyBench
Wenge AI released Decitron in June 2026 and describes it as the world's first general-purpose large decision model. It is built on three pillars: a World Model, multi-agent reasoning and game solving. On the PolyBench benchmark it achieved a Final Forecast Accuracy of 81.20%.
The model produces deduction process reports and comprehensive analysis reports for decision-makers. Its X-Signal global signal capability tracks evolving situations continuously.
ScienceOra launches on Tencent WorkBuddy with more than 30 research agents
ScienceOra is built on the ScienceOne Scientific Foundation Model and targets AI for Science (AI4S) workflows. Its recent launch on Tencent WorkBuddy brings more than 30 specialist research agents and skills. They cover literature analysis, hypothesis development, study design, modeling and simulation, validation and research communication.
In the booth demonstration, a drug R&D researcher evaluating Fostamatinib built a developability framework and analyzed the compound's ADMET characteristics against known bioactivity and toxicity data. The platform then proposed a follow-up validation plan with key metrics.
Checkie wins Invest Hong Kong semi-final slot and WSA 2026 nomination
Checkie is a consumer-facing tool that applies OCR and image analysis to uploaded PDFs or screenshots of contracts, freelance offers and dating profiles. It flags unusual details, such as clauses buried in a rental agreement or red flags in a job offer.
During the event, Invest Hong Kong named Checkie a Global Fast Track 2026 Semi-Finalist. It was also nominated as China's sole entry in the Government and Citizen Engagement category of the World Summit Awards (WSA) 2026, a United Nations-backed digital innovation award. It will compete in the upcoming global selection.